Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Genentech |
---|---|
Information provided by: | Genentech |
ClinicalTrials.gov Identifier: | NCT00473330 |
This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study of the efficacy and safety of ranibizumab injection in patients with CSME-CI secondary to diabetes mellitus (Type 1 or 2).
Condition | Intervention | Phase |
---|---|---|
Diabetes Mellitus Macular Edema |
Drug: ranibizumab Drug: sham |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment |
Official Title: | A Phase III, Double-Masked, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus |
Estimated Enrollment: | 366 |
Study Start Date: | July 2007 |
Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Drug: ranibizumab
Intravitreal injection repeating dose
|
2: Experimental |
Drug: ranibizumab
Intravitreal injection repeating dose
|
3: Sham Comparator |
Drug: sham
Intravitreal sham injection repeating dose
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Genentech Trial Information Support Line | 888-662-6728 |
Study Director: | Tsontcho Ianchulev, M.D., M.P.H. | Genentech |
Responsible Party: | Genentech, Inc. ( Clinical Trials Posting Group ) |
Study ID Numbers: | FVF4170g |
Study First Received: | May 13, 2007 |
Last Updated: | September 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00473330 |
Health Authority: | United States: Food and Drug Administration |
Lucentis DME Diabetes Vision Loss |
Metabolic Diseases Eye Diseases Diabetes Mellitus Edema Endocrine System Diseases Macular Degeneration Retinal Degeneration Blindness |
Macular Edema Signs and Symptoms Neoplasm Metastasis Endocrinopathy Metabolic disorder Glucose Metabolism Disorders Retinal Diseases Retinal degeneration |